Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$85.37 - $115.44 $26.1 Million - $35.3 Million
305,609 Added 1212.93%
330,805 $35.3 Million
Q4 2023

Oct 18, 2024

SELL
$69.51 - $104.43 $5.4 Million - $8.11 Million
-77,684 Reduced 75.51%
25,196 $2.51 Million
Q4 2023

Feb 09, 2024

SELL
$69.51 - $104.43 $5.4 Million - $8.11 Million
-77,684 Reduced 75.51%
25,196 $2.51 Million
Q3 2023

Oct 18, 2024

SELL
$96.41 - $126.61 $22.5 Million - $29.5 Million
-233,205 Reduced 69.39%
102,880 $10.6 Million
Q3 2023

Nov 13, 2023

SELL
$96.41 - $126.61 $22.5 Million - $29.5 Million
-233,205 Reduced 69.39%
102,880 $10.6 Million
Q2 2023

Oct 18, 2024

BUY
$118.5 - $160.53 $31.6 Million - $42.8 Million
266,888 Added 385.69%
336,085 $40.8 Million
Q2 2023

Aug 09, 2023

BUY
$118.5 - $160.53 $31.6 Million - $42.8 Million
266,888 Added 385.69%
336,085 $40.8 Million
Q1 2023

Oct 18, 2024

BUY
$135.66 - $197.02 $9.39 Million - $13.6 Million
69,197 New
69,197 $10.6 Million
Q1 2023

May 10, 2023

BUY
$135.66 - $197.02 $1.71 Million - $2.48 Million
12,599 Added 22.26%
69,197 $10.6 Million
Q4 2022

Oct 18, 2024

SELL
$118.38 - $210.04 $5.85 Million - $10.4 Million
-49,423 Reduced 46.62%
56,598 $10.2 Million
Q4 2022

Feb 09, 2023

SELL
$118.38 - $210.04 $5.85 Million - $10.4 Million
-49,423 Reduced 46.62%
56,598 $10.2 Million
Q3 2022

Oct 18, 2024

BUY
$118.07 - $194.18 $12.5 Million - $20.6 Million
106,021 New
106,021 $12.5 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $19.2 Million - $31.5 Million
-162,236 Reduced 60.48%
106,021 $12.5 Million
Q2 2022

Aug 10, 2022

BUY
$117.13 - $176.59 $31.4 Million - $47.4 Million
268,257 New
268,257 $38.3 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Intech Investment Management LLC Portfolio

Follow Intech Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intech Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intech Investment Management LLC with notifications on news.